8-K: Aramark Reports Record New Business, Strong FY25 Growth

Aramark announced robust fiscal 2025 results, driven by record new business wins, high client retention, and significant improvements in profitability and leverage, alongside a 14% dividend increase.

Summary

• Fiscal 2025 consolidated revenue was $18.5 billion, an increase of 6% year-over-year, with organic revenue growing 7%.
• Operating Income increased 12% year-over-year to $792 million, and Adjusted Operating Income (AOI) grew 12% to $981 million.
• GAAP EPS increased 23% to $1.22, while Adjusted EPS increased 19% to $1.82.
• The company achieved record annualized gross new business of $1.6 billion, more than 12% higher than fiscal 2024.
• Client retention rate reached 96.3%, the strongest in company history, leading to net new business at 5.6% of prior year revenue.
• The leverage ratio improved to 3.25x, marking the lowest level in nearly 20 years.
• Net cash from operations increased 27%, and Free Cash Flow grew 41% to $454 million.
• Aramark repurchased over 4 million shares and raised its quarterly dividend by 14%.
• Fourth quarter revenue increased 14% year-over-year (14% organically) to $5.0 billion.
• Fourth quarter Operating Income was unchanged at $218 million, while Adjusted Operating Income (AOI) grew 6% to $289 million.
• Fourth quarter GAAP EPS decreased 28% to $0.33, and Adjusted EPS increased 6% to $0.57.
• The 53rd week of operations contributed an estimated 2% to full-year revenue and 7% to fourth-quarter revenue.
• Additional incentive-based compensation of approximately $25 million in the fourth quarter impacted full-year Adjusted EPS by $0.07 (5%) and Q4 Adjusted EPS by $0.07 (13%).
• Fourth quarter GAAP EPS also included a non-cash asset impairment of $19.5 million associated with a minority interest investment.

Sentiment

Score: 8

Explanation: The filing reports strong financial performance across key metrics for fiscal 2025, including record new business, high retention, significant profitability growth, improved cash flow, and a reduced leverage ratio. The positive outlook for fiscal 2026 further reinforces confidence, despite some Q4 impacts from incentive compensation and asset impairment.

Positives

• Record Annualized Gross New Business of $1.6 billion, over 12% higher than fiscal 2024.
• Strongest client retention rate in company history at 96.3%, with many lines of business and countries even higher.
• Net New business at an unprecedented 5.6% of prior year revenue, including the largest contract win ever in FSS United States history.
• Full-year Organic Revenue grew 7% compared to the prior year period.
• Full-year Adjusted Operating Income (AOI) grew 12% (constant currency), with AOI margin expansion of nearly 25 basis points.
• Full-year Adjusted EPS increased 19% (constant currency) to $1.82.
• Achieved a Leverage Ratio of 3.25x, the lowest level in nearly 20 years.
• Net cash provided by operating activities increased 27% to $921 million.
• Free Cash Flow grew 41% to $454 million.
• Over $2.4 billion of cash availability at fiscal year-end.
• Repurchased in excess of 4 million shares of stock.
• Raised quarterly dividend by 14% to $0.12 per share.
• FSS United States revenue growth was led by strong net new business in Business & Industry, high retention and meal plan optimization in Education, and best performance in over two years for Healthcare.
• FSS International delivered strong revenue growth across geographies, particularly in the U.K., Canada, Ireland, Spain, and Latin America, with top-performing industries including Business & Industry, Healthcare, Education, and Extractive Services.

Negatives

• Additional incentive-based compensation of approximately $25 million recorded in the fourth quarter impacted full-year Adjusted EPS by $0.07 (5%) and Q4 Adjusted EPS by $0.07 (13%).
• Fourth quarter GAAP EPS decreased 28% to $0.33, partly due to a non-cash asset impairment of $19.5 million associated with a minority interest investment.
• Fourth quarter operating income was unchanged year-over-year despite higher revenue levels.
• A shift in the timing of new account openings towards the end of the fourth quarter somewhat offset revenue growth.
• Elevated expenses in the fourth quarter included approximately $25 million in incentive-based compensation, $5 million in certain medical prescription claims, and some new business start-up costs.
• Corporate expenses reflected higher incentive-based compensation.

Risks

• Unfavorable economic conditions.
• Natural disasters, global calamities, climate change, pandemics, energy shortages, sports strikes, and other adverse incidents.
• Geopolitical events, global supply chain disruptions, inflation, volatility, and disruption of global financial markets.
• The impact of the United States' and other countries' trade policies, including the implementation of tariffs.
• The failure to retain current clients, renew existing client contracts, and obtain new client contracts.
• A determination by clients to reduce their outsourcing or use of preferred vendors.
• Competition in our industries.
• Increased operating costs and obstacles to cost recovery due to the pricing and cancellation terms of our food and support services contracts.
• Currency risks and other risks associated with international operations, including compliance with a broad range of laws and regulations, such as the United States Foreign Corrupt Practices Act.
• Risks associated with suppliers from whom our products are sourced and disruptions to our relationship with our distribution partners.
• The contract-intensive nature of our business, which may lead to client disputes.
• The inability to hire and retain key or sufficiently qualified personnel or increases in labor costs.
• Our expansion strategy and our ability to successfully integrate the businesses we acquire and costs and timing related thereto.
• Continued or further unionization of our workforce.
• Liability resulting from our participation in multiemployer defined benefit pension plans.
• Laws and governmental regulations, including those relating to food and beverages, the environment, wage and hour, and government contracting.
• Liability associated with noncompliance with applicable law or other governmental regulations.
• New interpretations of or changes in the enforcement of the government regulatory framework.
• Increases or changes in income tax rates or tax-related laws.
• Potential liabilities, increased costs, reputational harm, and other adverse effects based on our commitments and stakeholder expectations relating to environmental, social, and governance considerations.
• The failure to maintain food safety throughout our supply chain, food-borne illness concerns, and claims of illness or injury.
• A cybersecurity incident or other disruptions in the availability of our computer systems or privacy breaches.
• The use of artificial intelligence technologies within our business processes.
• Our leverage and variable rate indebtedness that subjects us to interest rate risk.
• The inability to generate sufficient cash to service all of our indebtedness.
• Debt agreements that limit our flexibility in operating our business.
• Risks associated with the completed spin-off of Aramark Uniform and Career Apparel as an independent publicly traded company to our stockholders.

Future Outlook

For fiscal 2026, Aramark anticipates organic revenue growth of +7% to +9% (to a range of $19.55 billion $19.95 billion). Adjusted Operating Income growth (constant currency) is expected to be +12% to +17% (to a range of $1.1 billion $1.15 billion). Adjusted EPS growth (constant currency) is projected at +20% to +25% (to a range of $2.18 $2.28). The company also aims to reduce its Leverage Ratio to under 3x.

Management Comments

• "Fiscal 2025 represented many consequential milestones for the Company, contributing to the strong growth trajectory ahead." John Zillmer, Aramark CEO.
• "In addition to being awarded one of the most prestigious medical systems in the world, we delivered almost $1 billion in Annualized Net New business, added more than $1 billion of new purchasing spend in our Global Supply Chain network for a second consecutive year, and achieved a leverage ratio of 3.25x, a number we haven't seen since prior to when Aramark went private in 2007." John Zillmer, Aramark CEO.
• "We take delivering on our commitments very seriously. Our actions have centered on building a high performing business focused on providing exceptional hospitality to our clients and I want to reiterate that we are resolutely committed to achieving our financial objectives and generating significant shareholder value." John Zillmer, Aramark CEO.
• "We enter fiscal 2026 with great confidence. Our teams are focused on driving performance, and we are already seeing success in leveraging enterprise-wide capabilities, starting operations for a record number of new clients, maintaining our retention momentum, optimizing Global Supply Chain strategies, and lastly pursuing another year of significant growth opportunities." John Zillmer, Aramark CEO.

Industry Context

Aramark's strong performance in new business wins and high retention rates suggest a robust demand for outsourced food and facilities management services, indicating a broader industry trend where organizations seek efficiency, specialized expertise, and enhanced hospitality solutions. The company's focus on supply chain efficiencies and leveraging technology aligns with industry-wide efforts to mitigate inflationary pressures and improve operational margins. Securing the largest contract win in FSS United States history, particularly with a prestigious medical system, underscores Aramark's competitive strength and leadership in providing large-scale, high-value services in critical sectors.

Comparison to Industry Standards

• The 96.3% client retention rate is highlighted as the "strongest in Company history," positioning Aramark as a leader in client loyalty within the contract food and facilities management industry.
• Achieving a leverage ratio of 3.25x, described as the "lowest level in nearly 20 years," indicates a significantly improved financial position compared to historical performance and potentially against more highly leveraged competitors in the service sector.
• The "largest contract win ever in FSS United States history" with "one of the most prestigious medical systems in the world" demonstrates Aramark's superior competitive capabilities and market leadership in securing high-profile, large-scale contracts.

Legal Proceedings

• Legal charges related to an anti-trust review ($1.4 million for the fourth quarter of 2025 and $2.5 million for fiscal 2025).
• Charges related to a ruling on a foreign payroll tax matter ($6.8 million for both the fourth quarter and fiscal 2024).

Stakeholder Impact

• Shareholders benefited from a 14% increase in the quarterly dividend, repurchases of over 4 million shares, and strong financial performance leading to increased EPS and a positive outlook.
• Employees were impacted by additional incentive-based compensation ($25 million in Q4) for achieving record net new business, and severance charges from restructuring initiatives.
• Clients benefited from high retention rates (96.3%) and the company's focus on providing exceptional hospitality and seamless transitions for new accounts.
• Creditors were positively impacted by the improved leverage ratio (3.25x) and the company's commitment to further reduce leverage below 3.0x, indicating stronger financial health.

Next Steps

• Commencement of operations for the largest contract win in FSS United States history early in the new fiscal year.
• Continued focus on driving performance, leveraging enterprise-wide capabilities, and optimizing Global Supply Chain strategies in fiscal 2026.
• Pursuing another year of significant growth opportunities in fiscal 2026.
• Actions taken to decrease future medical expenses, specifically related to certain elective lifestyle prescriptions.
• Continued proactive actions to further enhance the strong balance sheet and reduce the leverage ratio below 3.0x.
• Grow quarterly dividend payments.
• Repurchase Aramark stock using excess cash generation.

Key Dates

Recommendation

The company delivered exceptional fiscal 2025 results, marked by record new business wins, robust client retention, and significant improvements in profitability and cash flow. The leverage ratio is at a nearly 20-year low, and the company is actively returning capital to shareholders through a 14% dividend increase and share repurchases. The fiscal 2026 outlook projects strong continued growth in revenue, operating income, and EPS, indicating sustained positive momentum. While there were some one-off expenses in Q4, the underlying business performance and strategic direction are very strong, making it an attractive investment.

Keywords

Aramark, ARMK, fiscal 2025 earnings, Q4 2025 results, financial performance, revenue growth, operating income, EPS, net new business, client retention, leverage ratio, dividend increase, share repurchase, food services, facilities management, hospitality, cash flow, outlook